Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lH-pyrrolizin-5-ylacetic acid

Details for Australian Patent Application No. 2006226625 (hide)

Owner Merckle GmbH

Inventors Kammermeier, Thomas; Laufer, Stefan; Albrecht, Wolfgang; Merckle, Philipp; Striegel, Hans-Gunter

Agent Freehills

Pub. Number AU-B-2006226625

PCT Pub. Number WO2006/100019

Priority 10 2005 012 971.4 21.03.05 DE

Filing date 20 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 21 April 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/100019 Priority application(s): WO2006/100019

21 April 2011 Application Accepted

  Published as AU-B-2006226625

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226627-Use of the Mst protein for the treatment of a thromboembolic disorder

2006226624-Polysiloxane coated metal oxide particles